Design Therapeutics Competitors and Similar CompaniesClear all
Abliva's competitors and similar companies include Thor Medical.
 Abliva Abliva is a biotech company that discovers and develops medicines for the treatment of mitochondrial disease. |  Thor Medical Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology. | |
Founding Date | Founding Date 2000 | Founding Date 2009 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Lund, SE HQ | Locations Oslo, NO HQ Zug, CH Shrewsbury, GB |
Employees | Employees 950% increase | Employees 3716% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr439k (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit kr497k (FY, 2024) | Gross profit kr4.3m (FY, 2025) |
Net income | Net income (kr90m) (FY, 2024) | Net income (kr58m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Thor Medical
HQ
Oslo, NO
Employees
37↓ 16% decrease
Thor Medical (formerly known as Nordic Nanovector) is a biopharmaceutical company that focuses on the development and commercialisation of novel targeted therapeutics in haematology and oncology.
View company